Literature DB >> 11115289

Simultaneous vocal fold and tongue paresis secondary to Epstein-Barr virus infection.

M M Johns1, N D Hogikyan.   

Abstract

Dysphonia is a common presenting symptom in cases referred for otolaryngologic evaluation. Similarly, primary care physicians frequently see adolescents or young adults with symptomatic Epstein-Barr virus infection. Some of the patients with active Epstein-Barr virus infection who have severe clinical manifestations of infectious mononucleosis will be referred for otolaryngologic evaluation. Voice abnormalities in these patients, though, are usually limited to altered resonance due to pharyngeal crowding by hyperplastic lymphoid tissue. We describe a patient with infectious mononucleosis who was referred for evaluation of dysphonia and was diagnosed with unilateral tongue and vocal fold paresis. We also discuss the patient's clinical course and review the related literature. Although uncommon, cranial nerve palsies must be considered in the patient with Epstein-Barr virus infection who presents with voice or speech disturbance. Arch Otolaryngol Head Neck Surg. 2000;126:1491-1494

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115289     DOI: 10.1001/archotol.126.12.1491

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  Unilateral Vocal Cord Paralysis of a Great Jewish Opera Singer.

Authors:  Irit Duek; Jacob T Cohen; Ziv Gil
Journal:  Rambam Maimonides Med J       Date:  2018-01-29

2.  Oculomotor Nerve Palsy as a Presenting Symptom of Epstein-Barr Virus-Associated Infectious Mononucleosis: Case Report and Review of the Literature.

Authors:  Leon Amadeus Steiner; Aslihan Erbay; Florence Pache; Moritz Niederschweiberer; Eberhard Siebert; Karen Gertz; Klemens Ruprecht
Journal:  Case Rep Neurol       Date:  2021-11-29

3.  Epstein-Barr virus-associated infectious mononucleosis with acute epididymitis: a case report.

Authors:  Kentaro Sako; Tsuneaki Kenzaka; Ayako Kumabe
Journal:  BMC Infect Dis       Date:  2022-02-10       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.